Compare LQDT & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LQDT | DRTS |
|---|---|---|
| Founded | 1999 | 2015 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2005 | 2021 |
| Metric | LQDT | DRTS |
|---|---|---|
| Price | $44.60 | $13.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $51.00 | $17.80 |
| AVG Volume (30 Days) | 190.4K | ★ 439.3K |
| Earning Date | 11-19-2026 | 11-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.10 | N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | ★ $476,669,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1,235.59 |
| P/E Ratio | $57.29 | ★ N/A |
| Revenue Growth | ★ 31.20 | N/A |
| 52 Week Low | $21.67 | $3.43 |
| 52 Week High | $45.92 | $15.79 |
| Indicator | LQDT | DRTS |
|---|---|---|
| Relative Strength Index (RSI) | 54.75 | 45.13 |
| Support Level | $36.82 | $11.24 |
| Resistance Level | $45.92 | $13.95 |
| Average True Range (ATR) | 1.06 | 0.62 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 51.20 | 62.37 |
Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Retail Supply Chain Group (RSCG), and Machinio & Software Solutions. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.